arteriovenous malformations
Conditions
Interventions
Group 1:absolute ethanol
Group 2:Oynx
Sponsors
Shanghai Ninth People Hospital, School of Medicine, Shanghai Jiaotong University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) There was no history of AVMs treatment, including intervention and surgery. (2) According to the diagnostic criteria of AVMs, arteriovenous shunt and abnormal vascular mass were found. (3) Patients with good compliance and no contraindications. (4) There were imaging findings. (5) The patients and their families agreed and signed the informed consent.
Exclusion criteria
Exclusion criteria: (1) Pregnant and lactating women, history of drug allergy, liver and kidney dysfunction, heart and lung dysfunction. (2) After treatment, the patients who did not meet the design requirements or may affect the test results, such as misdiagnosis of arteriovenous malformation, were carefully differentiated. (3) The subjects dropped out. (4) Patients who quit the experiment before the end of treatment, such as death, automatic discharge, etc. (5) In the course of treatment allergic acute attack cases. (6) If the course of treatment is not over, the patient withdraws from the trial or dies due to other reasons. (7) Those who could not be followed up and naturally separated during observation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the rate of nidus; | — |
Secondary
| Measure | Time frame |
|---|---|
| recurrence rate;Incidence of complications; | — |
Countries
China
Contacts
Public ContactXindong Fan
Shanghai Ninth People Hospital, School of Medicine, Shanghai Jiaotong University
Outcome results
None listed